Pyrido<3,2-c>-1H-1,2-diazepin | 67434-45-1

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 英文名称: Pyrido<3,2-c>-1H-1,2-diazepin
• 英文别名: 1H-pyrido[3,2-c][1,2]diazepine；1H-Pyrido[3,2-c][1,2]diazepine；1H-pyrido[3,2-c]diazepine
• CAS: 67434-45-1
• 化学式: C₈H₇N₃
• 分子量: 145.164
• InChiKey: VCJCULBSFIZKLM-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.9
• 重原子数：
  11
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  37.3
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  Pyrido<3,2-c>-1H-1,2-diazepin 、 氢化铝锂 生成 2,3-dihydro-1H-pyrido[3,2-c]diazepine
  参考文献：
  名称：

  TSUCHIYA T.; ENKARU M.; SAWANISHI H., CHEM. AND PHARM. BULL., 1979, 27, NO 9, 2188-2193

  摘要：

  DOI：
• 作为产物：
  描述：

  1,5-Naphthyridin-1-ium-1-ylazanide 生成 Pyrido<3,2-c>-1H-1,2-diazepin
  参考文献：
  名称：

  SAWANISHI HIROYKI; ENKAKU MICHIKO; TSUCHIYA TAKASHI, HETEROCYCLES, 1979, 12, NO 1, 214

  摘要：

  DOI：

文献信息

• Benzodiazepine and Pyridodiazepine Derivatives
  申请人：Bunnelle William H.

  公开号：US20110288069A1

  公开（公告）日：2011-11-24

  The present application relates to benzodiazepine and pyridodiazepine derivatives of formula (I) wherein R 1 , R 2 , R 3 , R 4 , X 1 , Y 1 , Y 2 , and Y 3 are as defined in the specification. The present application also relates to compositions comprising such compounds, and methods of treating disease conditions using such compounds and compositions, and methods for identifying such compounds.

  本申请涉及式(I)的苯二氮卓和吡啶二氮卓衍生物，其中R1、R2、R3、R4、X1、Y1、Y2和Y3如规范中所定义。本申请还涉及包含这类化合物的组合物，以及使用这类化合物和组合物治疗疾病症状的方法，以及识别这类化合物的方法。
• [EN] PYRROLO [2,1-C]1,4]NAPHTHODIAZEPINE LINKED PIPERAZINE COMPOUNDS AND A PROCESS FOR THE PREPARATION THEREOF<br/>[FR] COMPOSÉS DE PIPÉRAZINE LIÉS À LA PYRROLO [2,1-C][1,4]NAPHTHODIAZÉPINE ET PROCÉDÉ DE PRÉPARATION
  申请人：COUNCIL SCIENT IND RES

  公开号：WO2012111020A1

  公开（公告）日：2012-08-23

  The present invention provides a compound of general formula A, useful as potential antitumour agents against five human cancer cell lines. The present invention further provides a process for the preparation of pyrrolo[2,1-c][1,4]naphthodiazepine linked substituted piperazine conjugates attached through different alkane spacers of general formula A. (Formula I) General formula A. Where R= R'= (Formula II). n=1-9 and R''= methyl, ethyl, acetyl, benzyl, piperinoyl, 4-fluorophenyl, 4-chlorophenyl, 4-methoxyphenyl, pyridyl, pyrimidyl

  本发明提供了一种一般式A的化合物，可作为潜在的抗肿瘤剂用于对抗五种人类癌细胞系。本发明还提供了一种制备嘧啶并[2,1-c][1,4]萘二氮杂环己烷取代哌嗪共轭物的过程，通过一般式A的不同烷烃间隔连接。 (式I) 一般式A。其中R= R'= (式II)。n=1-9，R''= 甲基，乙基，乙酰基，苄基，哌啶酰基，4-氟苯基，4-氯苯基，4-甲氧基苯基，吡啶基，嘧啶基
• SMALL MOLECULE REGULATORS OF STEROID RECEPTOR COACTIVATORS AND METHODS OF USE THEREOF
  申请人：BAYLOR COLLEGE OF MEDICINE

  公开号：US20170290830A1

  公开（公告）日：2017-10-12

  Small molecule regulators of steroid receptor coactivator (SRC) family proteins are provided, as well as methods for their use in treating or preventing SRC-related diseases. The SRC-related diseases can include cancer, metabolic disorders, human immunodeficiency virus, neurodegenerative disorders, and/or inflammatory diseases. Also provided are methods for regulating SRC family proteins in a cell.

  提供了小分子调节类固醇受体共激活子（SRC）家族蛋白的方法，以及它们在治疗或预防SRC相关疾病中的应用。SRC相关疾病可以包括癌症、代谢紊乱、人类免疫缺陷病毒、神经退行性疾病和/或炎症性疾病。还提供了在细胞中调节SRC家族蛋白的方法。
• [EN] INHIBITORS OF BROMODOMAIN-CONTAINING PROTEIN 4 (BRD4)<br/>[FR] INHIBITEURS DE PROTÉINE 4 CONTENANT UN BROMODOMAINE (BRD4)
  申请人：ZHOU JIA

  公开号：WO2018112037A1

  公开（公告）日：2018-06-21

  Certain embodiments are directed to small molecule selective inhibitors of the BRD4 bromodomain. Compounds described herein can be used to modulate the bronchiolar NFkB-BRD4 axis, which plays a role in acute neutrophilic response to viral molecular patterns. Compounds described herein can be developed as preventive and therapeutic agents for various human diseases and conditions.

  某些实施例涉及BRD4溴结构域的小分子选择性抑制剂。本文描述的化合物可用于调节支气管NFκB-BRD4轴，该轴在对病毒分子模式的急性中性粒细胞反应中起作用。本文描述的化合物可作为各种人类疾病和病况的预防和治疗药物开发。
• TRICYCLIC KINASE INHIBITORS AND USE THEREOF
  申请人：Namdev Nivedita

  公开号：US20210070731A1

  公开（公告）日：2021-03-11

  The present application provides novel compounds that are inhibitors of kinases, including AMPK-related kinases like NUAK1, NUAK2, SIK1, SIK2, SIK3, MARK1, MARK2, MARK3, MARK4, as well as AURKA, AURKB, AURKC, CLK1, CLK2, DCAMKL2, MAPK7, MKNK2, PIK3CD, PKN3, RET, TAOK1, TAOK2, TAOK3, ULK2 and their mutants. The application also provides compositions, including pharmaceutical compositions, kits that include compounds, and methods of making and using compounds. The compounds provided herein are useful in treating diseases, disorders, or conditions that are mediated by these kinases.

  本申请提供了一种新型化合物，它们是激酶的抑制剂，包括AMPK相关激酶如NUAK1、NUAK2、SIK1、SIK2、SIK3、MARK1、MARK2、MARK3、MARK4，以及AURKA、AURKB、AURKC、CLK1、CLK2、DCAMKL2、MAPK7、MKNK2、PIK3CD、PKN3、RET、TAOK1、TAOK2、TAOK3、ULK2及其突变体。本申请还提供了包括药物组合物、包含化合物的试剂盒，以及制备和使用化合物的方法。本文提供的化合物可用于治疗由这些激酶介导的疾病、疾病或症状。